Stuart A. Arbuckle - Jul 1, 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Jul 1, 2025
Transactions value $
-$16,767,916
Form type
4
Date filed
7/2/2025, 04:16 PM
Previous filing
Jun 26, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arbuckle Stuart A EVP, COO C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON /s/ Christiana Stevenson, Attorney-in-Fact 2025-07-02 0001557290

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$16.8M -37.2K -37.02% $450.23 63.4K Jul 1, 2025 Direct
holding VRTX Common Stock 140 Jul 1, 2025 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Stuart A. Arbuckle is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.